GLG News by Managed Care Pricing Trends Experts

While pharmaceutical companies raised prices at a higher level than general inflation, implementing price controls is not the appropriate means to control drug spend.  More effort needs to be placed on clinical trials and the demonstration of efficacy and value prior to a products release. ...

Naturally Police Departments are concerned about the weight of their officers, given the physical nature of the work for those on the beat, but this issue is beginning to be raised in the general employer arena.  For employers to be successful with this type of approach, they need to go beyond...

Hurting ATM usage, or not, by adjusting fees is the least of our problems. The problem is Washington and the Credit Card Fair Fee Act of 2008.

    Ongoing healthcare inflation at 200-400%/yr of  CPI has surpassed the point where employers can easily compete with international products and services.  We are already seeing growth in Scheduled Medical Benefits, which are a poor substitute - but do substitute for...

Mental health is undoubtedly a most important issue, but this is another instance of being backdoored into national healthcare.

Health plans [insurers] cannot control healthcare costs: (1) it is not their role and purpose (2) they are not providers of medical services (3) they are subject to, and operate in, a mature market, and (4) they have been neutered by regulation and politics.      ...

Health Plans are going to have to radically change their systems and approaches if they expect to improve their success in the long run.  The system as currently structured dis-incents Health Plans from doing the right thing, actually managing health.  This requires a long term commitment...

The reason Marsh is struggling is because of poor leadership ending up with $850,000,000+ in fines from NY, IL and CT for bid rigging and prohibited contingency fees.  Future profitability & growth for these brokerages is anything but certain and likely to grow very slowly because they are...

1. Controlled release preparations are often better tolerated with fewer side effects than immediate release preparations 2. OCD and SAD are severe, highly prevalent and chronically disabling conditions 3. Despite presence of SSRIs and other treatment, e.g, cognitive behavioral therapy, up to 1/3 of...

1. Despite common use of multiple psychotropic medications for bipolar disorder in youth, there are few FDA-approved treatments 2. Abilify is one of the safest and best tolerated of the atypical antipsychotics with fewer side effects than some of the other atypical antipsychotic medications 3. This...